In cohorts, eating more fish is associated with slightly fewer deaths, strokes, and dementia. In trials, fatty fish lowers triglycerides, whereas lean fish does not, and no link appears with diabetes. If pregnant, choose fish low in mercury.
“Strong” = several concordant meta-analyses or systematic reviews. “Moderate” = one synthesis, or several controlled trials. “Limited” = early trials only. The rating is about the quality of the studies, not about how useful the supplement is.

Pixabay · CC0
From two 113 g portions to 750 g of fish per week in trials; in cohorts, the link with dementia plateaus at 250 g per week.
Mercury: a review of 164 studies in 43 countries finds methylmercury levels above FAO and WHO reference values in women and infants among certain high-fish-consuming populations, notably near artisanal gold mining. Pregnancy: choose fish low in mercury, recommends the review on child brain development. Limitations: diabetes: across 12 cohorts and 438,214 people, eating fish 5 times a week or more is not associated with less diabetes. Cholesterol: in 79 people with high fasting blood glucose, 4 meals of fatty or lean fish per week for 12 weeks changed neither blood glucose nor inflammation, and camelina oil improved cholesterol better. Unchanged triglycerides: in 36 adults with high triglycerides, lean and fatty fish for 8 weeks did not lower triglycerides, nor did krill oil. Children: in 232 children aged 4 to 6 years, herring or mackerel three times a week for 16 weeks did not improve cognition in the main analysis. Like lean beef: out of 8 trials, beef and poultry or fish change cholesterol in the same way. Associations: links with mortality, stroke, and dementia come from cohorts, and for mortality they are seen mostly in Asian studies.
In 38 young adults, 750 g of cod per week changed nothing regarding triglycerides, whereas the same amount of salmon lowered them.
This meta-analysis of 35 observational studies suggests that high fish consumption is associated with a reduced risk of cognitive impairment (18%), dementia (18%), and Alzheimer's disease (20%). A dose-response analysis showed a significant decrease in the risk of cognitive impairment of up to 30% for a consumption of 150g/day. For dementia and Alzheimer's disease, additional studies are needed to strengthen the evidence.
Godos J, Micek A, Currenti W, Franchi C, Poli A, Battino M, Dolci A, Ricci C, Ungvari Z, Grosso G. — Aging clinical and experimental research (2024) — View the source study
For information only: not a substitute for medical advice. Dietary supplements are not a replacement for a varied, balanced diet. Learn more